Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DerIch
    Junior Member
    • Dec 2013
    • 2

    #1

    How to subtract a coverage track of mock IP from a set of ChIP tracks?

    I have a set of ChIP data, most of them with a transcription factor, but also control data, which was not the raw input chromatin, but instead they performed a "mock" ChIP, i.e. pulled out chromatin with a bead on which no antibodies were attached.

    This mock track shows a strong co-movement with the actual ChIP tracks, which made me wonder if there is a way to correct this bias in the actual ChIP tracks. My first naive idea would be to just subtract the mock track from the ChIP tracks. This is of course not smart, but hopefully clarifies what I'm looking for.

    Does anyone know of literature that addresses this problem?
  • crazyhottommy
    Senior Member
    • Apr 2012
    • 187

    #2
    you can use MACS2 for this object
    if you have bedgraph file
    MACS -- Model-based Analysis of ChIP-Seq. Contribute to macs3-project/MACS development by creating an account on GitHub.


    if you have wig file


    use wigmath subtract

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...